1. Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells
   Marta Pelon et al, 2024, Frontiers in Pharmacology CrossRef
2. Vemurafenib induces senescence in acute myeloid leukemia and myelodysplastic syndrome by activating the HIPPO signaling pathway: implications for potential targeted therapy
   Qiao Zhou et al, 2024, Biology Direct CrossRef